1. Home
  2. CEV vs BNTC Comparison

CEV vs BNTC Comparison

Compare CEV & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEV
  • BNTC
  • Stock Information
  • Founded
  • CEV 1999
  • BNTC 1995
  • Country
  • CEV United States
  • BNTC United States
  • Employees
  • CEV N/A
  • BNTC N/A
  • Industry
  • CEV Finance/Investors Services
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CEV Finance
  • BNTC Health Care
  • Exchange
  • CEV Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • CEV 75.9M
  • BNTC 88.1M
  • IPO Year
  • CEV N/A
  • BNTC N/A
  • Fundamental
  • Price
  • CEV $10.40
  • BNTC $10.20
  • Analyst Decision
  • CEV
  • BNTC Strong Buy
  • Analyst Count
  • CEV 0
  • BNTC 5
  • Target Price
  • CEV N/A
  • BNTC $22.60
  • AVG Volume (30 Days)
  • CEV 19.6K
  • BNTC 32.3K
  • Earning Date
  • CEV 01-01-0001
  • BNTC 11-14-2024
  • Dividend Yield
  • CEV 4.23%
  • BNTC N/A
  • EPS Growth
  • CEV N/A
  • BNTC N/A
  • EPS
  • CEV 0.36
  • BNTC N/A
  • Revenue
  • CEV N/A
  • BNTC N/A
  • Revenue This Year
  • CEV N/A
  • BNTC N/A
  • Revenue Next Year
  • CEV N/A
  • BNTC N/A
  • P/E Ratio
  • CEV $29.36
  • BNTC N/A
  • Revenue Growth
  • CEV N/A
  • BNTC N/A
  • 52 Week Low
  • CEV $8.83
  • BNTC $2.69
  • 52 Week High
  • CEV $10.91
  • BNTC $12.89
  • Technical
  • Relative Strength Index (RSI)
  • CEV 39.01
  • BNTC 48.29
  • Support Level
  • CEV $10.36
  • BNTC $9.10
  • Resistance Level
  • CEV $10.44
  • BNTC $10.93
  • Average True Range (ATR)
  • CEV 0.08
  • BNTC 0.62
  • MACD
  • CEV 0.00
  • BNTC -0.09
  • Stochastic Oscillator
  • CEV 18.18
  • BNTC 58.51

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Share on Social Networks: